Vitamin D
hormonalAlso known as: Cholecalciferol (D3), Ergocalciferol (D2), Calciferol
About
A fat-soluble vitamin with receptors in adipose tissue, skeletal muscle, and the pancreas. Mendelian randomization studies confirm a causal association between low vitamin D levels and higher BMI, and meta-analyses support supplementation for metabolic health in deficient individuals.
How It Works
Vitamin D receptors are expressed in adipose tissue, skeletal muscle, and the pancreas. Adequate vitamin D status supports insulin sensitivity, leptin signaling, and calcium-mediated fat oxidation. Deficiency (25(OH)D <20 ng/mL) is independently associated with obesity, insulin resistance, and increased visceral fat — potentially through impaired adipocyte differentiation and increased parathyroid hormone (PTH).
Evidence For Conditions
| Condition | Grade | Studies | Participants | |
|---|---|---|---|---|
| PCOS-Related Weight Management | B | 12 | 800 | View → |
| Obesity | B | 11 | 947 | View → |
| Menopause-Related Weight Gain | C | 6 | 500 | View → |
Side Effects
- Hypercalcemia (at very high doses)
- Nausea
- Kidney stones (at excessive doses)
Drug & Supplement Interactions
- Statins (may increase statin levels)
- Thiazide diuretics (increased calcium risk)
- Corticosteroids (impair vitamin D metabolism)
- Orlistat (reduced absorption)
Always inform your healthcare provider about all supplements you take.
Related Ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.